BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54
22 results:

  • 1. IKZF4/nono-RAB11FIP3 axis promotes immune evasion in gastric cancer via facilitating PD-L1 endosome recycling.
    Weng N; Zhou C; Zhou Y; Zhong Y; Jia Z; Rao X; Qiu H; Zeng G; Jin X; Zhang J; Zhuang Z; Liang Z; Deng Y; Li Q; Yang S; Luo H; Wang H; Wu X
    Cancer Lett; 2024 Mar; 584():216618. PubMed ID: 38211652
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. circ-hnRNPU inhibits nono-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression.
    Li H; Jiao W; Song J; Wang J; Chen G; Li D; Wang X; Bao B; Du X; Cheng Y; Yang C; Tong Q; Zheng L
    J Exp Clin Cancer Res; 2023 Nov; 42(1):313. PubMed ID: 37993881
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer.
    Cui H; Qu Y; Zhang L; Zhang W; Yan P; Yang C; Zhang M; Bai Y; Tang M; Wang Y; Chen L; Xiao C; Zou Y; Liu Y; Zhang L; Yang Y; Yao Y; Li J; Liu Z; Yang C; Jiang X; Zhang B
    Int J Cancer; 2023 Jul; 153(2):320-330. PubMed ID: 37074298
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic cancer Risk From 5 Prospective Cohorts.
    Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
    Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of the relationship between oipA, babA2, babB genotypes and helicobacter pylori-related gastric precancerous lesions.
    Yang K; Shi L; Chen J
    J Pak Med Assoc; 2023 Feb; 73(2):249-252. PubMed ID: 36800704
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma.
    Jin Y; Cao J; Cheng H; Hu X
    J Chemother; 2023 Nov; 35(7):638-652. PubMed ID: 36797828
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LINC00963: A potential cancer diagnostic and therapeutic target.
    Xie Z; Zhong C; Shen J; Jia Y; Duan S
    Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. H. pylori infection alters repair of DNA double-strand breaks via SNHG17.
    Han T; Jing X; Bao J; Zhao L; Zhang A; Miao R; Guo H; Zhou B; Zhang S; Sun J; Shi J
    J Clin Invest; 2020 Jul; 130(7):3901-3918. PubMed ID: 32538894
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. DEAD-Box Protein RNA-Helicase DDX6 Regulates the Expression of HER2 and FGFR2 at the Post-Transcriptional Step in gastric cancer Cells.
    Tajirika T; Tokumaru Y; Taniguchi K; Sugito N; Matsuhashi N; Futamura M; Yanagihara K; Akao Y; Yoshida K
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987267
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ets-1 promoter-associated noncoding RNA regulates the nono/ERG/Ets-1 axis to drive gastric cancer progression.
    Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
    Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells.
    Taniguchi K; Iwatsuki A; Sugito N; Shinohara H; Kuranaga Y; Oshikawa Y; Tajirika T; Futamura M; Yoshida K; Uchiyama K; Akao Y
    Mol Carcinog; 2018 May; 57(5):579-589. PubMed ID: 29314290
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and nono.
    Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
    Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan.
    Sun W; Wen CP; Lin J; Wen C; Pu X; Huang M; Tsai MK; Tsao CK; Wu X; Chow WH
    Cancer Epidemiol; 2015 Apr; 39(2):150-6. PubMed ID: 25600007
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer.
    Franchini M; Lippi G
    BMC Med; 2015 Jan; 13():7. PubMed ID: 25592962
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study.
    Etemadi A; Kamangar F; Islami F; Poustchi H; Pourshams A; Brennan P; Boffetta P; Malekzadeh R; Dawsey SM; Abnet CC; Emadi A
    BMC Med; 2015 Jan; 13():8. PubMed ID: 25592833
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ABO blood groups and risk of cancer: a systematic review and meta-analysis.
    Zhang BL; He N; Huang YB; Song FJ; Chen KX
    Asian Pac J Cancer Prev; 2014; 15(11):4643-50. PubMed ID: 24969898
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells.
    Iio A; Takagi T; Miki K; Naoe T; Nakayama A; Akao Y
    Biochim Biophys Acta; 2013 Oct; 1829(10):1102-10. PubMed ID: 23932921
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. ABO blood group system and gastric cancer: a case-control study and meta-analysis.
    Wang Z; Liu L; Ji J; Zhang J; Yan M; Zhang J; Liu B; Zhu Z; Yu Y
    Int J Mol Sci; 2012 Oct; 13(10):13308-21. PubMed ID: 23202954
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. NO-releasing NSAIDs suppress NF-κB signaling in vitro and in vivo through S-nitrosylation.
    Chattopadhyay M; Goswami S; Rodes DB; Kodela R; Velazquez CA; Boring D; Crowell JA; Kashfi K
    Cancer Lett; 2010 Dec; 298(2):204-11. PubMed ID: 20674154
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Helicobacter pylori infection in gastric cancerogenesis.
    Konturek PC; Konturek SJ; Brzozowski T
    J Physiol Pharmacol; 2009 Sep; 60(3):3-21. PubMed ID: 19826177
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.